Biogen and Neomorph Forge Collaboration to Develop Molecular Glue Degraders for Neurological and Immunological Diseases

 Biogen Inc. (Nasdaq: BIIB) and Neomorph Inc. announced a research collaboration to discover and develop molecular glue degraders for priority ta...

October 30, 2024 | Wednesday | News
GC Biopharma and Novelty Nobility Form Strategic South Korea-Based Alliance to Develop Novel Treatment for Geographic Atrophy (GA)

GC Biopharma announced that it has signed an agreement with Novelty Nobility, a biotech company specializing in the development of antibody-based therape...

October 28, 2024 | Monday | News
AbbVie and Gedeon Richter Forge New Agreement to Explore Treatments for Neuropsychiatric Disorders

 AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') announced a new discovery, co-development and license agreement to advance novel targets for ...

October 25, 2024 | Friday | News
Florida Lung Health Coalition and DELFI Diagnostics Launch Initiative to Transform Lung Cancer Screening

In a groundbreaking alliance announced, the Florida Lung Health Coalition and DELFI Diagnostics, supported by RadNet, Inc. (NASDAQ: RDNT), and the Ame...

October 23, 2024 | Wednesday | News
Grifols Partners with BARDA to Develop Eye Drops for Sulfur Mustard Ocular Injury

Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, announced it has established a...

October 23, 2024 | Wednesday | News
Samsung Biologics Secures Landmark $1.24 Billion Contract with Asia-Based Pharma

INCHEON, South Korea, Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced a contra...

October 22, 2024 | Tuesday | News
Sanofi and CD&R Announce Exclusive Negotiations for 50% Stake in Opella, Poised to Create Global Consumer Healthcare Leader

 Sanofi and CD&R announce a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. S...

October 22, 2024 | Tuesday | News
Sanofi Partners with Orano Med to Pioneer Next-Generation Radioligand Therapies for Rare Cancers

  Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into ...

October 17, 2024 | Thursday | News
PacBio Partners with Singapore’s National Cancer Centre to Advance Cancer Research in Asia

PacBio , a leading developer of high-quality, highly accurate sequencing solutions,  announced the signing of a new Research Collaboration Agre...

October 14, 2024 | Monday | News
Basilea Pharmaceutica Secures $1.25 Million Milestone Payment Following Strong Sales of Cresemba® in Asia Pacific and China

Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and ...

October 10, 2024 | Thursday | News
BD Partners with ten23 Health to Enhance Prefillable Syringe Traceability with RFID Technology

 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ten23 health, the human-centri...

October 07, 2024 | Monday | News
Amira Hovione and Zerion Pharma Expand Partnership to Accelerate Development of Dispersome® Technology

Hovione Farmaciência, S.A.(“HOVIONE”) and Zerion Pharma A/S (“ZERION”) today announced that they have expanded their part...

October 04, 2024 | Friday | News
Renaissance Lakewood Begins U.S. Manufacturing of FDA-Approved neffy®, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis

Renaissance Lakewood, LLC (“Renaissance”), a leading global contract development and manufacturing organization (“CDMO”) is proud...

October 04, 2024 | Friday | News
Recipharm and Exela Pharma Forge Strategic Alliance to Boost U.S. Sterile Manufacturing with 100+ Million Units Capacity

Sterile manufacturing capability in the US with over 100 million readily-available units (including vials and Pre-Filled Syringes – PFS) Extensi...

October 04, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close